The global tissue diagnostics market is projected to grow at a CAGR of 6.35% during 2026–2031, driven by increasing cancer prevalence, rising adoption of precision medicine, and growing demand for advanced pathology and biomarker testing solutions. North America currently leads the market, while Asia-Pacific is emerging as a high-growth region.
Hyderabad, India, May 21, 2026 (GLOBE NEWSWIRE) — According to the latest report by Mordor Intelligence, the tissue diagnostics market size is projected to grow from USD 6.45 billion in 2025 to USD 6.86 billion in 2026, and is expected to reach USD 9.33 billion by 2031, registering a CAGR of 6.35% during 2026–2031, supported by increasing utilization of biomarker-based diagnostics and rising demand for personalized treatment strategies. The market expansion is driven by advancements in immunohistochemistry, in situ hybridization, molecular diagnostics, and digital pathology technologies that are improving disease detection accuracy and supporting targeted therapy selection.
Market growth is fueled by the increasing burden of cancer and the growing need for early and accurate diagnosis. Healthcare providers and pathology laboratories are increasingly utilizing tissue diagnostic technologies to identify disease biomarkers, assess tumor characteristics, and guide personalized treatment decisions. The growing emphasis on precision oncology and companion diagnostics is further strengthening demand for advanced tissue diagnostics solutions across healthcare systems globally.
The market is also benefiting from increasing investments in cancer research, expanding use of biomarker-based testing, and rising collaborations between pharmaceutical companies, biotechnology firms, and diagnostic providers. Tissue diagnostics solutions are increasingly being utilized in oncology drug development, biomarker discovery, and clinical research applications, contributing to broader market adoption. Rising awareness regarding early cancer screening and improvements in healthcare infrastructure are further supporting market expansion globally.
Tissue Diagnostics Market Share by Region
North America represents a significant share of the tissue diagnostics market, driven by advanced healthcare infrastructure, strong adoption of precision medicine technologies, and increasing investments in oncology research and pathology modernization.
Asia-Pacific is emerging as a high-growth region due to increasing cancer incidence, expanding healthcare infrastructure, rising investments in molecular diagnostics, and growing adoption of advanced pathology services across countries such as China, India, Japan, and South Korea.
Europe holds a notable position in the market, supported by increasing healthcare investments, expanding pathology digitization initiatives, and rising utilization of companion diagnostics and biomarker-based testing.
“The Tissue Diagnostics Market reflects a steadily evolving healthcare landscape where demand is increasingly tied to precision-focused testing and pathology workflows. Mordor Intelligence combines structured primary research, multi-source validation, and consistent analytical frameworks to deliver commercially reliable market assessments aligned with observable industry developments.” Says, Soumya Goud, Senior Research Manager, Mordor Intelligence
Tissue Diagnostics Market Trends & Forecast
Growing Adoption of Precision Oncology and Companion Diagnostics
Healthcare providers are increasingly utilizing tissue-based biomarker testing and companion diagnostics to improve treatment accuracy and support personalized cancer care.
Advancements in Digital Pathology and AI-Assisted Diagnostics
Innovations in digital pathology platforms, AI-enabled image analysis, and automated tissue processing systems are improving diagnostic precision and laboratory efficiency.
Tissue Diagnostics Market Segmentation Overview
- By Product
-
- Instruments
- Slide-staining systems
- Tissue-processing systems
- Whole-slide scanners
- Microtomes & cryostats
- Other Instruments
-
- Reagents and Consumables
- Antibodies
- Kits & assays
- Reagents & probes
- Other consumables
- By Technology
-
- Immunohistochemistry
-
- In-situ Hybridization
-
- Digital Pathology
-
- Other Technologies
- By Application
-
- Breast Cancer
-
- Prostate Cancer
-
- Non-Small Cell Lung Cancer
-
- Gastric Cancer
-
- Lymphoma
-
- Others
- By End User
-
- Hospitals and Diagnostic Laboratories
-
- Pharmaceutical and Biotechnology Companies
-
- Research & Academic Institutes
-
- Others
- By Geography
-
- North America
-
-
- United States
-
-
-
- Canada
-
-
-
- Mexico
-
-
- Europe
-
-
- Germany
-
-
-
- United Kingdom
-
-
-
- France
-
-
-
- Italy
-
-
-
- Spain
-
-
-
- Rest of Europe
-
-
- Asia-Pacific
-
-
- China
-
-
-
- Japan
-
-
-
- India
-
-
-
- Australia
-
-
-
- South Korea
-
-
-
- Rest of Asia-Pacific
-
-
- Middle East and Africa
-
-
- GCC
-
-
-
- South Africa
-
-
-
- Rest of Middle East and Africa
-
-
- South America
-
-
- Brazil
-
-
-
- Argentina
-
-
-
- Rest of South America
-
For a full breakdown of market dynamics, segmentation insights, regional analysis, and competitive landscape, access the details of the Mordor Intelligence report: https://www.mordorintelligence.com/industry-reports/global-tissue-diagnostics-market-industry?utm_source=globenewswire
Tissue Diagnostics Market Competitive Outlook
The tissue diagnostics market features diagnostic companies, pathology technology providers, and molecular diagnostics firms focusing on expanding advanced testing capabilities, improving laboratory automation, and enhancing precision diagnostic services. Market participants are investing in digital pathology platforms, AI-enabled analytics tools, and automated tissue processing technologies to strengthen operational efficiency and diagnostic accuracy. Strategic collaborations, product innovation, and expansion of biomarker testing portfolios are also shaping competitive dynamics within the market.
Major Companies in the Tissue Diagnostics Market include:
- F. Hoffmann-La Roche Ltd
- Danaher Corporation
- Thermo Fisher Scientific Inc.
- Agilent Technologies, Inc.
- Abbott Laboratories
Check out related reports published by Mordor Intelligence:
Flow Cytometry Market Size – The flow cytometry market is estimated to grow from USD 7.27 billion in 2026 to USD 10.53 billion by 2031, registering a CAGR of 7.69% during the forecast period. Growth is driven by increasing applications in immunology and cancer research, rising demand for advanced cell analysis technologies, and expanding use in clinical diagnostics and drug discovery.
Microbiology Testing Market Share -The microbiology testing market is estimated to grow from USD 6.7 billion in 2026 to USD 10.35 billion by 2031, registering a CAGR of 9.09% during the forecast period. Market expansion is supported by increasing prevalence of infectious diseases, rising demand for rapid diagnostic testing, and growing adoption of automated microbiology solutions in laboratories.
Hemoglobin Testing Devices Market Trends -The hemoglobin testing devices market is estimated to grow from USD 4.28 billion in 2026 to USD 5.91 billion by 2031, registering a CAGR of 6.67% during the forecast period. Growth is driven by increasing prevalence of anemia and blood disorders, rising demand for point-of-care diagnostics, and growing awareness of routine blood health monitoring.
Read about Mordor Intelligence:
Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.
With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.
CONTACT: For any inquiries, please contact: media@mordorintelligence.com https://www.mordorintelligence.com/contact-us
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Publication takes no editorial responsibility for the same.
